| |
| |
|
| Insider
Information: |
Green David |
| Relationship: |
Interim CEO, Director |
| City: |
Holliston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,084,432 |
|
|
Indirect Shares
|
251,364 |
|
|
| Direct
Value |
$3,506,243 |
|
|
|
Indirect Value
|
$834,503 |
|
|
| Total
Shares |
1,335,796 |
|
|
| Total
Value |
$4,340,746 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 49.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harvard Bioscience Inc |
HBIO |
Director |
2017-02-07 |
925,571 |
2017-02-07 |
234,896 |
Premium* |
|
|
Biostage Inc |
BSTG |
Interim CEO, Director |
2022-05-12 |
158,861 |
2022-05-12 |
16,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,300 |
472,339 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-05-27 |
4 |
OE |
$2.56 |
$573,153 |
D/D |
223,888 |
682,540 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-05-27 |
4 |
D |
$3.54 |
$638,315 |
D/D |
(180,315) |
502,225 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-06-01 |
4 |
D |
$3.83 |
$292,512 |
D/D |
(76,374) |
504,910 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-06-01 |
4 |
OE |
$3.64 |
$287,775 |
D/D |
79,059 |
581,284 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,300 |
530,210 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,600 |
542,810 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2017-02-06 |
4 |
AS |
$3.25 |
$4,186 |
D/D |
(1,288) |
928,810 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2017-02-07 |
4 |
AS |
$3.25 |
$10,527 |
D/D |
(3,239) |
925,571 |
0 |
- |
|
| BSTG |
Biostage Inc |
Interim CEO |
• • – |
2021-11-26 |
4 |
B |
$3.45 |
$250,001 |
D/D |
72,464 |
95,516 |
2.81 |
% |
|
| BSTG |
Biostage Inc |
Interim CEO |
• • – |
2022-05-12 |
4 |
B |
$5.92 |
$375,002 |
D/D |
63,345 |
158,861 |
2.81 |
% |
|
136 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
